T. Rowe Price Associates’s Aceragen, Inc. Common Stock ACGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-3,556
| Closed | -$62K | – | 3056 |
|
2021
Q3 | $62K | Hold |
3,556
| – | – | ﹤0.01% | 2892 |
|
2021
Q2 | $72K | Buy |
3,556
+2,596
| +270% | +$52.6K | ﹤0.01% | 2868 |
|
2021
Q1 | $21K | Hold |
960
| – | – | ﹤0.01% | 2833 |
|
2020
Q4 | $60K | Buy |
960
+359
| +60% | +$22.4K | ﹤0.01% | 2642 |
|
2020
Q3 | $22K | Hold |
601
| – | – | ﹤0.01% | 2573 |
|
2020
Q2 | $18K | Hold |
601
| – | – | ﹤0.01% | 2486 |
|
2020
Q1 | $13K | Hold |
601
| – | – | ﹤0.01% | 2494 |
|
2019
Q4 | $19K | Hold |
601
| – | – | ﹤0.01% | 2505 |
|
2019
Q3 | $29K | Hold |
601
| – | – | ﹤0.01% | 2494 |
|
2019
Q2 | $27K | Sell |
601
-14
| -2% | -$629 | ﹤0.01% | 2521 |
|
2019
Q1 | $27K | Hold |
615
| – | – | ﹤0.01% | 2514 |
|
2018
Q4 | $29K | Buy |
+615
| New | +$29K | ﹤0.01% | 2528 |
|
2018
Q3 | – | Sell |
-288
| Closed | -$52K | – | 2604 |
|
2018
Q2 | $52K | Sell |
288
-316
| -52% | -$57.1K | ﹤0.01% | 2553 |
|
2018
Q1 | $151K | Buy |
604
+324
| +116% | +$81K | ﹤0.01% | 2440 |
|
2017
Q4 | $80K | Buy |
+280
| New | +$80K | ﹤0.01% | 2510 |
|